BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25143363)

  • 1. Pulmonary transplantation of macrophage progenitors as effective and long-lasting therapy for hereditary pulmonary alveolar proteinosis.
    Happle C; Lachmann N; Škuljec J; Wetzke M; Ackermann M; Brennig S; Mucci A; Jirmo AC; Groos S; Mirenska A; Hennig C; Rodt T; Bankstahl JP; Schwerk N; Moritz T; Hansen G
    Sci Transl Med; 2014 Aug; 6(250):250ra113. PubMed ID: 25143363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Transplantation of Human Induced Pluripotent Stem Cell-derived Macrophages Ameliorates Pulmonary Alveolar Proteinosis.
    Happle C; Lachmann N; Ackermann M; Mirenska A; Göhring G; Thomay K; Mucci A; Hetzel M; Glomb T; Suzuki T; Chalk C; Glage S; Dittrich-Breiholz O; Trapnell B; Moritz T; Hansen G
    Am J Respir Crit Care Med; 2018 Aug; 198(3):350-360. PubMed ID: 29652170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis.
    Lachmann N; Happle C; Ackermann M; Lüttge D; Wetzke M; Merkert S; Hetzel M; Kensah G; Jara-Avaca M; Mucci A; Skuljec J; Dittrich AM; Pfaff N; Brennig S; Schambach A; Steinemann D; Göhring G; Cantz T; Martin U; Schwerk N; Hansen G; Moritz T
    Am J Respir Crit Care Med; 2014 Jan; 189(2):167-82. PubMed ID: 24279725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective hematopoietic stem cell-based gene therapy in a murine model of hereditary pulmonary alveolar proteinosis.
    Hetzel M; Lopez-Rodriguez E; Mucci A; Nguyen AHH; Suzuki T; Shima K; Buchegger T; Dettmer S; Rodt T; Bankstahl JP; Malik P; Knudsen L; Schambach A; Hansen G; Trapnell BC; Lachmann N; Moritz T
    Haematologica; 2020 Apr; 105(4):1147-1157. PubMed ID: 31289207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TALEN-mediated functional correction of human iPSC-derived macrophages in context of hereditary pulmonary alveolar proteinosis.
    Kuhn A; Ackermann M; Mussolino C; Cathomen T; Lachmann N; Moritz T
    Sci Rep; 2017 Nov; 7(1):15195. PubMed ID: 29123113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary alveolar proteinosis: time to shift?
    Papiris SA; Tsirigotis P; Kolilekas L; Papadaki G; Papaioannou AI; Triantafillidou C; Papaporfyriou A; Karakatsani A; Kagouridis K; Griese M; Manali ED
    Expert Rev Respir Med; 2015 Jun; 9(3):337-49. PubMed ID: 25864717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine iPSC-Derived Macrophages as a Tool for Disease Modeling of Hereditary Pulmonary Alveolar Proteinosis due to Csf2rb Deficiency.
    Mucci A; Kunkiel J; Suzuki T; Brennig S; Glage S; Kühnel MP; Ackermann M; Happle C; Kuhn A; Schambach A; Trapnell BC; Hansen G; Moritz T; Lachmann N
    Stem Cell Reports; 2016 Aug; 7(2):292-305. PubMed ID: 27453007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. iPSC-Derived Macrophages Effectively Treat Pulmonary Alveolar Proteinosis in Csf2rb-Deficient Mice.
    Mucci A; Lopez-Rodriguez E; Hetzel M; Liu S; Suzuki T; Happle C; Ackermann M; Kempf H; Hillje R; Kunkiel J; Janosz E; Brennig S; Glage S; Bankstahl JP; Dettmer S; Rodt T; Gohring G; Trapnell B; Hansen G; Trapnell C; Knudsen L; Lachmann N; Moritz T
    Stem Cell Reports; 2018 Sep; 11(3):696-710. PubMed ID: 30100408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary macrophage transplantation therapy.
    Suzuki T; Arumugam P; Sakagami T; Lachmann N; Chalk C; Sallese A; Abe S; Trapnell C; Carey B; Moritz T; Malik P; Lutzko C; Wood RE; Trapnell BC
    Nature; 2014 Oct; 514(7523):450-4. PubMed ID: 25274301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic Hematopoietic Stem Cell Transplantation After Prior Lung Transplantation for Hereditary Pulmonary Alveolar Proteinosis: A Case Report.
    Beeckmans H; Ambrocio GPL; Bos S; Vermaut A; Geudens V; Vanstapel A; Vanaudenaerde BM; De Baets F; Malfait TLA; Emonds MP; Van Raemdonck DE; Schoemans HM; Vos R
    Front Immunol; 2022; 13():931153. PubMed ID: 35928826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 beta c receptor-deficient mice despite correction of alveolar proteinosis after BMT.
    Cooke KR; Nishinakamura R; Martin TR; Kobzik L; Brewer J; Whitsett JA; Bungard D; Murray R; Ferrara JL
    Bone Marrow Transplant; 1997 Oct; 20(8):657-62. PubMed ID: 9383229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of alveolar proteinosis by intrapulmonary transplantation of macrophages].
    Borie R; Danel C; Lainé C; Kannengiesser C; Crestani B
    Med Sci (Paris); 2015 Mar; 31(3):241-4. PubMed ID: 25855273
    [No Abstract]   [Full Text] [Related]  

  • 13. [Response to inhaled granulocyte-macrophage colony-stimulating factor in a patient with alveolar proteinosis].
    Rodríguez Portal JA; Rodríguez Becerra E; Sánchez Garrido A
    Arch Bronconeumol; 2009 Mar; 45(3):150-2. PubMed ID: 19286115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy of beta(c)-deficient pulmonary alveolar proteinosis (beta(c)-PAP): studies in a murine in vivo model.
    Kleff V; Sorg UR; Bury C; Suzuki T; Rattmann I; Jerabek-Willemsen M; Poremba C; Flasshove M; Opalka B; Trapnell B; Dirksen U; Moritz T
    Mol Ther; 2008 Apr; 16(4):757-64. PubMed ID: 18334984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Patient with autoimmune alveolar proteinosis who did not respond to GM-CSF inhalation therapy and underwent repeated whole-lung lavage].
    Ueda Y; Matsuo K; Tsushima M; Mizuta M; Fujiwara K; Yonei T; Sato T
    Nihon Kokyuki Gakkai Zasshi; 2009 Sep; 47(9):833-8. PubMed ID: 19827590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-macrophage colony-stimulating factor and pulmonary surfactant homeostasis.
    Reed JA; Whitsett JA
    Proc Assoc Am Physicians; 1998; 110(4):321-32. PubMed ID: 9686680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary alveolar proteinosis.
    Khan A; Agarwal R
    Respir Care; 2011 Jul; 56(7):1016-28. PubMed ID: 21496372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.
    Huizar I; Kavuru MS
    Curr Opin Pulm Med; 2009 Sep; 15(5):491-8. PubMed ID: 19561506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report.
    Tazawa R; Nakata K; Inoue Y; Nukiwa T
    Respirology; 2006 Jan; 11 Suppl():S61-4. PubMed ID: 16423274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary alveolar proteinosis: progress in the first 44 years.
    Seymour JF; Presneill JJ
    Am J Respir Crit Care Med; 2002 Jul; 166(2):215-35. PubMed ID: 12119235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.